DIAGNOSBusiness Directories,Company Directories

Company Name: Corporate Name:	DIAGNOS
Company Title:
Company Description:
Keywords to Search:
Company Address:	1175 Lavigerie Ave,SAINTE-FOY,QC,Canada
ZIP Code: Postal Code:	G1V
Telephone Number:	4182669904
Fax Number:
Website:
Email:
USA SIC Code(Standard Industrial Classification Code):	0
USA SIC Description:	ACCOUNTANTS
Number of Employees:
Sales Amount:
Credit History: Credit Report:
Contact Person:
Remove my name

Company Directories & Business Directories

copy and paste this google map to your website or blog!

Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples:
WordPress Example, Blogger Example)

Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer

(Any information to deal,buy, sell, quote for products or service)

Previous company profile:
DIAL TEXTILE LTEE
DIAGNOS INC
DIAGNOCURE INC

Next company profile:
DIABETIQUES DE QUEBEC KIOSQUE
DIABETIQUES DE QUEBEC KIOSQUE
DIABETIQUES DE QUEBEC

Company News:

Home - Diagnos
Diagnos is a leader in artificial intelligence and healthcare technical services including algorithm development, data analysis, and image processing ever since 2001
DIAGNOS fait le point sur sa demande dhomologation dun instrument . . .
En tirant parti de l'intelligence artificielle, DIAGNOS vise à fournir plus d'informations aux cliniciens en soins de santé afin d'améliorer la précision des diagnostics, de rationaliser les flux de travail et d'améliorer les résultats pour les patients à l'échelle mondiale
DIAGNOS Files FDA Pre-Submission for its CARA System: Strategic Entry . . .
The CARA System—DIAGNOS’ cloud-based platform—is designed to inform optometrists by providing AI-assisted analysis of retinal images to detect indicators of Diabetic Retinopathy (DR), Hypertensive Retinopathy (HR), Age-Related Macular Degeneration (ARMD), and other vascular or macular anomalies
DIAGNOS Financial Statements
DIAGNOS Inc Consolidated Statements of Changes in Equity (amounts in Canadian dollars) The accompanying notes are an integral part of these Consolidated Financial Statements
DIAGNOS dépose une pré-soumission auprès de la FDA pour son système . . .
En tirant parti de l'intelligence artificielle, DIAGNOS vise à fournir plus d'informations aux cliniciens en soins de santé afin d'améliorer la précision des diagnostics, de rationaliser les flux de travail et d'améliorer les résultats pour les patients à l'échelle mondiale
DIAGNOS is filing for the Saudi FDA Authorization of Its CARA SYSTEM
DIAGNOS is a publicly traded Canadian corporation dedicated to early detection of critical health problems based on its FLAIRE Artificial Intelligence (AI) platform
DIAGNOS Opens First US Office in Florida
By leveraging Artificial Intelligence, DIAGNOS aims to provide more information to healthcare clinicians to enhance diagnostic accuracy, streamline workflows, and improve patient outcomes on a global scale
DIAGNOS Welcomes Dr. Barry A. Ginsberg to its Advisory Board for the US . . .
By leveraging Artificial Intelligence, DIAGNOS aims to provide more information to healthcare clinicians to enhance diagnostic accuracy, streamline workflows, and improve patient outcomes on a global scale
DIAGNOS Provides Update on its Health Canada Medical Device Licence . . .
Following the submission of its application in early September, DIAGNOS has engaged in ongoing communication with Health Canada, providing timely responses to all regulatory requests